Boston Scientific acquires remainder of cardiac device maker for $295M

Boston Scientific has pulled the trigger on its option to acquire the remaining stake in Farapulse, a California-based maker of cardiac devices. The company had held a 27% stake in Farapulse since 2014; now, with an upfront payment of $295 million, Boston Scientific is the sole owner of Farapulse.